1H-IMidazole-5-carboxylic acid, 4-(1-hydroxy-1-Methylethyl)-2-propyl-1-[[2'-[1-(triphenylMethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]Methyl]-, ethyl ester
|
|
|
- CAS-Nr.
- 144690-33-5
- Englisch Name:
- 1H-IMidazole-5-carboxylic acid, 4-(1-hydroxy-1-Methylethyl)-2-propyl-1-[[2'-[1-(triphenylMethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]Methyl]-, ethyl ester
- Synonyma:
- OMSTINT-J;Olmesartan Medoxomil-19;Olmesartan ester impurity 28;Trityl olMesartan ethyl ester;Olmesartan Medoxomil Impurity 28;Olmesartan Medoxomil Impurity 31;Azilsartan medoxomil impurity229;OlMesartan Ethyl Ester Trityl IMpurity;5-(4'-(dibromomethyl)-[1,1'-biphenyl]-2-yl)-1H-tetrazole;1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-...
- CBNumber:
- CB72570964
- Summenformel:
- C45H44N6O3
- Molgewicht:
- 716.87
- MOL-Datei:
- 144690-33-5.mol
|
1H-IMidazole-5-carboxylic acid, 4-(1-hydroxy-1-Methylethyl)-2-propyl-1-[[2'-[1-(triphenylMethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]Methyl]-, ethyl ester Eigenschaften
- Schmelzpunkt:
- 161℃
- Siedepunkt:
- 889.7±75.0 °C(Predicted)
- Dichte
- 1.18±0.1 g/cm3(Predicted)
- storage temp.
- Sealed in dry,Room Temperature
- L?slichkeit
- Chloroform (Slightly), Methanol (Slightly)
- Aggregatzustand
- Solid
- pka
- 13.18±0.29(Predicted)
- Farbe
- White to Off-White
- Wasserl?slichkeit
- 4.6μg/L at 25℃
- LogP
- 9.64 at 25℃
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
| Bildanzeige (GHS) |
|
| Alarmwort |
|
| Gefahrenhinweise |
| Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
| H413 |
Kann für Wasserorganismen sch?dlich sein, mit langfristiger Wirkung. |
Langfristig (chronisch) gew?ssergef?hrdend |
Kategorie 4 |
|
|
|
|
| Sicherheit |
|
1H-IMidazole-5-carboxylic acid, 4-(1-hydroxy-1-Methylethyl)-2-propyl-1-[[2'-[1-(triphenylMethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]Methyl]-, ethyl ester Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
Tritylolmesartan Ethyl Ester is an impurity of olmesartan medoxomil (O550000), an angiotensin II receptor antagonist and anti-hypertensive drug.
1H-IMidazole-5-carboxylic acid, 4-(1-hydroxy-1-Methylethyl)-2-propyl-1-[[2'-[1-(triphenylMethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]Methyl]-, ethyl ester Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
1H-IMidazole-5-carboxylic acid, 4-(1-hydroxy-1-Methylethyl)-2-propyl-1-[[2'-[1-(triphenylMethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]Methyl]-, ethyl ester Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 131)Lieferanten
144690-33-5()Verwandte Suche:
- 1H-IMidazole-5-carboxylic acid, 4-(1-hydroxy-1-Methylethyl)-2-propyl-1-[[2'-[1-(triphenylMethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]Methyl]-, ethyl ester
- Trityl olMesartan ethyl ester
- OlMesartan Ethyl Ester Trityl IMpurity
- 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid ethyl ester
- 1H-IMidazole-5-carboxylic acid, 4-(1-hydroxy-1-Methylethyl)-2-propyl-1-[[2'-[1
- Ethyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-5-carboxylate
- OMSTINT-J
- Olmesartan Medoxomil-19
- Ethyl 4-(2-hydroxy-2-propanyl)-2-propyl-1-{[2'-(1-trityl-1H-tetra zol-5-yl)-4-biphenylyl]methyl}-1H-imidazole-5-carboxylate
- Olmesartan Medoxomil Impurity 31
- Olmesartan Medoxomil Impurity 28
- 5-(4'-(dibromomethyl)-[1,1'-biphenyl]-2-yl)-1H-tetrazole
- Olmesartan Medoxomil impurity 2/Olmesartan Ethyl Ester Trityl Impurity/Ethyl 4-(2-Hydroxypropan-2-yl)-2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-5-carboxylate
- 4-(1-Hydroxy-1-methylethyl)-2-propyl-1[4-[2-(trityltetrazol-5-yl)phenyl]phenyl]methylimidazo-5-carboxylate ethyl
- 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol
- 1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-...
- Azilsartan medoxomil impurity229
- Olmesartan ester impurity 28
- Ethyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-(2(2-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)ethyl)-1H-imidazole-5-carboxylate
- Ethyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-5-carboxylate
- 1H-IMidazole-5-carboxylic acid, 4-(1-hydroxy-1-Methylethyl)-2-propyl-1-[[2'-[1-(triphenylMethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]Methyl]-, ethyl ester
- Olmesartan Ethyl Ester Trityl Impurity
1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2- propyl-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'- biphenyl]-4-yl]methyl]-, ethyl ester' Ethyl 4-(1-hydroxy-1- methylethyl)-2-propyl-1-[4-[2-(trityltetrazol-5-
- 2-propyl-1-[[2'-[1-(triphenylMethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]Methyl]-, ethyl ester
- Ethyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-5-carboxylate (Olmesartan Medoxomi Impurity)
- Ethyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-5-carboxylate (Olmesartan Medoxomi Impurity)
- 144690-33-5
